Preview
Full Doc
 | 2009 | | | |
Preview
Full Doc
 | 2009 | | | |
Full Doc
 | 2008 |
Collaboration and License Agreement
Collaboration and License Agreement (6K)
Doc #3333229: This document is immediately available for purchase, but does not have a preview available for viewing.
3333229
| | |
Preview
Full Doc
 | 2008 | | | |
Preview
Full Doc
 | 2008 | | | |
Preview
Full Doc
 | 2008 | | | |
Preview
Full Doc
 | 2008 | | | |
Preview
Full Doc
 | 2008 | | | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (119K)
Doc #2707002: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
THIS COLLABORATION AND LICENSE AGREEMENT (the �Agreement�) is made as of October 29, 2004, by and between Sucampo Pharmaceuticals, Inc., a corporation organized under the laws of Delaware, having its principal place of business at 4733 Bethesda Avenue, Suite 450, Bethesda, Maryland 20814 USA (�SPI�), and Takeda Pharmaceutical Company Limited, a corporation organized under the laws of Japan, having its principal place of business at 1-1 Doshomachi 4-chome, Chuo-ku, Osaka 540-8645, Japan (�Takeda�). SPI and Takeda are . . .
2707002
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (275K)
Doc #2713819: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
BY AND BETWEEN
ALTUS PHARMACEUTICALS INC.
AND
GENENTECH, INC.
DATED AS OF DECEMBER 19, 2006
This COLLABORATION AND LICENSE AGREEMENT (this "Agreement"), dated as of
December 19, 2006 (the "Execution Date"), is made by and between Altus
Pharmaceuticals Inc., a Delaware corporation having its principal office at 125
Sidney . . .
2713819
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (105K)
Doc #2743932: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
THIS COLLABORATION AND LICENSE AGREEMENT (�Agreement�) is made and entered into effective as of January 5, 2005 (the �Effective Date�), by and among ONCOGENEX TECHNOLOGIES INC., having offices at #400 � 1001 West Broadway, Vancouver, B.C., V6H 4B1 (�OncoGenex�) and ISIS PHARMACEUTICALS, INC., having principal offices at 2292 Faraday Avenue, Carlsbad CA 92008 (�Isis�). OncoGenex and Isis each may be referred to herein individually as a �Party,� or collectively as the �Parties.�
WHEREAS, Isis and OncoGenex wish to collaborate in the . . .
2743932
|
Alnylam Pharma
As referenced in this Collaboration and License Agreement:
Alnylam Pharmaceuticals, Inc – each case such activities will not be interpreted as a breach of this Agreement. In addition, the Parties acknowledge that Isis entered into a Strategic Collaboration and License Agreement with Alnylam Pharmaceuticals, Inc . dated March 11, 2004 and that Alnylam may independently discover and develop Antisense Compounds against Collaboration Gene Targets; however, Isis will not grant Alnylam any Isis Patent Rights specifically _____________
dt 1723602
| |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (92K)
Doc #2743933: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
THIS COLLABORATION AND LICENSE AGREEMENT (�Agreement�) is made and entered into effective as of August 31, 2003 (the �Effective Date�), by and among ONCOGENEX TECHNOLOGIES INC., having offices at Jack Bell Research Centre, Rm 550, 2660 Oak Street, Vancouver, B.C., V6H 3Z6 (�OncoGenex�) and ISIS PHARMACEUTICALS, INC., having principal offices at 2292 Faraday Avenue, Carlsbad CA 92008 (�Isis�). OncoGenex and Isis each may be referred to herein individually as a �Party,� or collectively as the �Parties.�
WHEREAS, Isis and OncoGenex wish to . . .
2743933
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (184K)
Doc #2751043: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the �Agreement�) is made and entered into effective as of December 3, 2004 (the �Effective Date�) by and between Micromet AG, having its principal place of business at Staffelseestrasse 2, 81477, Munich, Germany (�Micromet�), and Ares Trading S.A., having its principal place of business at Zone Industrielle de l�Ouriettaz, CH-1170 Aubonne, Switzerland (�Serono�). Micromet and Serono each may be referred to herein individually as a �Party,� or collectively as the �Parties.� . . .
2751043
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (190K)
Doc #2751051: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the �Agreement�) is made and entered into effective as of June 6, 2003 (the �Effective Date�), by and between Micromet AG, having its principal place of business at Staffelseestrasse 2, 81477, Munich, Germany (�Micromet�), and MedImmune, Inc., having its principal place of business at 35 W. Watkins Mill Road, Gaithersburg, MD 20878 (�MedImmune�). Micromet and MedImmune each may be referred to herein individually as a �Party,� or collectively as the �Parties.�
Recitals
. . .
2751051
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (184K)
Doc #2751161: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the �Agreement�) is made and entered into effective as of December 3, 2004 (the �Effective Date�) by and between Micromet AG, having its principal place of business at Staffelseestrasse 2, 81477, Munich, Germany (�Micromet�), and Ares Trading S.A., having its principal place of business at Zone Industrielle de l�Ouriettaz, CH-1170 Aubonne, Switzerland (�Serono�). Micromet and Serono each may be referred to herein individually as a �Party,� or collectively as the �Parties.� . . .
2751161
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (190K)
Doc #2751169: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the �Agreement�) is made and entered into effective as of June 6, 2003 (the �Effective Date�), by and between Micromet AG, having its principal place of business at Staffelseestrasse 2, 81477, Munich, Germany (�Micromet�), and MedImmune, Inc., having its principal place of business at 35 W. Watkins Mill Road, Gaithersburg, MD 20878 (�MedImmune�). Micromet and MedImmune each may be referred to herein individually as a �Party,� or collectively as the �Parties.�
Recitals
. . .
2751169
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (184K)
Doc #2760523: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the �Agreement�) is made and entered into effective as of December 3, 2004 (the �Effective Date�) by and between Micromet AG, having its principal place of business at Staffelseestrasse 2, 81477, Munich, Germany (�Micromet�), and Ares Trading S.A., having its principal place of business at Zone Industrielle de l�Ouriettaz, CH-1170 Aubonne, Switzerland (�Serono�). Micromet and Serono each may be referred to herein individually as a �Party,� or collectively as the �Parties.� . . .
2760523
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (190K)
Doc #2760531: Click preview link for longer preview.
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the �Agreement�) is made and entered into effective as of June 6, 2003 (the �Effective Date�), by and between Micromet AG, having its principal place of business at Staffelseestrasse 2, 81477, Munich, Germany (�Micromet�), and MedImmune, Inc., having its principal place of business at 35 W. Watkins Mill Road, Gaithersburg, MD 20878 (�MedImmune�). Micromet and MedImmune each may be referred to herein individually as a �Party,� or collectively as the �Parties.�
Recitals
. . .
2760531
| | |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (86K)
Doc #2760723: Click preview link for longer preview.
Portions of this document have been redacted. Redacted sections marked with �*****.�
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the �Agreement�) between AVI BioPharma, Inc. of One S.W. Columbia, Suite 1105, Portland OR 97258 (�AVI�) and ERCOLE BIOTECH, INC., of 79 TW Alexander Dr., Bldg 4401, Suite 200, Research Triangle Park, NC 27709 (�Ercole�) is entered into and made effective this 19th day of December 2006 (the �Effective Date�).
OVERVIEW
Collaboration and Cross Licenses
AVI owns or controls certain patents related to morpholino chemistry (the . . .
2760723
|
AVI BioPharma
As referenced in this Collaboration and License Agreement:
AVI BioPharma, Inc – htm EX-10.56
Exhibit 10.56
Portions of this document have been redacted. Redacted sections marked with ?*****.?
COLLABORATION AND LICENSE AGREEMENT
This Collaboration and License Agreement (the ?Agreement?) between AVI BioPharma, Inc . of One S.W. Columbia, Suite 1105, Portland OR 97258 (?AVI?) and ERCOLE BIOTECH, INC., of 79 TW Alexander Dr., Bldg 4401, Suite 200, Research Triangle Park, NC 27709 (? _____________
AVI BioPharma, Inc – original, but all of which together will constitute one and the same instrument.
IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date.
Ercole Biotech, Inc.
AVI BioPharma, Inc .
By:
By:
Name:
Name:
Title:
Title:
EXHIBIT 1
DEFINITIONS
1.1 ?Active Program? means with respect to a Gene Target, an Ercole-AVI Exclusive Target or an AVI Exclusive _____________
dt 1732970
| |
Preview
Full Doc
 | 2007 |
Collaboration and License Agreement
Collaboration and License Agreement (204K)
Doc #2805292: Click preview link for longer preview.
CONFIDENTIAL
COLLABORATION AND LICENSE AGREEMENT
This COLLABORATION AND LICENSE AGREEMENT (this �Agreement�) is entered into as of the 29th day of August, 2006 (the �Effective Date�) by and between NovaCal Pharmaceuticals, Inc., a California corporation, having its principal place of business at 5980 Horton Street, Suite 550, Emeryville, California 94608 (�NovaCal�) and Alcon Manufacturing, Ltd., a Texas partnership, having its principal place of business at 6201 S. Freeway, Fort Worth, Texas 76134-2099 (�Alcon�). NovaCal and Alcon are each referred to herein by name or, individually, . . .
2805292
| | |